Go offline with the Player FM app!
New Mitral Frontier ๐ช๐ซ๐ถโโ๏ธ TMVR Opens a Third Pathway
Manage episode 517580999 series 2740117
A new era for complex mitral regurgitation.
The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (โ96% โค1+ at 1 year), low early mortality, and meaningful improvement in symptoms and quality of life for patients unsuitable for surgery or TEER.
A third pathway for mitral disease is emergingโone built on precision access, valve-in-valve durability planning, and advancing patient selection.
Innovation meeting clinical need. ๐๐ซ๐
772 episodes
Manage episode 517580999 series 2740117
A new era for complex mitral regurgitation.
The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (โ96% โค1+ at 1 year), low early mortality, and meaningful improvement in symptoms and quality of life for patients unsuitable for surgery or TEER.
A third pathway for mitral disease is emergingโone built on precision access, valve-in-valve durability planning, and advancing patient selection.
Innovation meeting clinical need. ๐๐ซ๐
772 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.